A detailed history of Ethic Inc. transactions in Novartis Ag stock. As of the latest transaction made, Ethic Inc. holds 132,747 shares of NVS stock, worth $13.1 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
132,747
Previous 140,957 5.82%
Holding current value
$13.1 Million
Previous $15 Million 1.75%
% of portfolio
0.38%
Previous 0.36%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $871,327 - $992,506
-8,210 Reduced 5.82%
132,747 $15.3 Million
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $759,999 - $881,507
8,210 Added 6.18%
140,957 $15 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $760,921 - $866,349
7,987 Added 6.4%
132,747 $12.8 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $1.09 Million - $1.2 Million
11,780 Added 10.43%
124,760 $12.6 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $1.28 Million - $1.42 Million
13,489 Added 13.56%
112,980 $11.5 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $149,142 - $169,114
-1,612 Reduced 1.59%
99,491 $10 Million
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $215,360 - $249,751
-2,691 Reduced 2.59%
101,103 $9.3 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $2.53 Million - $3.1 Million
33,521 Added 47.7%
103,794 $9.42 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $866,371 - $1.01 Million
-11,612 Reduced 14.18%
70,273 $5.34 Million
Q2 2022

Aug 10, 2022

BUY
$80.52 - $93.75 $370,230 - $431,062
4,598 Added 5.95%
81,885 $6.92 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $2.96 Million - $3.35 Million
37,008 Added 91.88%
77,287 $6.78 Million
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $284,050 - $314,095
3,564 Added 9.71%
40,279 $3.52 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $1.05 Million - $1.22 Million
12,850 Added 53.84%
36,715 $3 Million
Q2 2021

Aug 10, 2021

BUY
$85.24 - $94.15 $1.08 Million - $1.19 Million
12,675 Added 113.27%
23,865 $2.18 Million
Q1 2021

May 13, 2021

BUY
$83.5 - $98.47 $180,527 - $212,892
2,162 Added 23.95%
11,190 $957,000
Q4 2020

Feb 10, 2021

BUY
$78.07 - $94.43 $303,692 - $367,332
3,890 Added 75.71%
9,028 $853,000
Q3 2020

Oct 27, 2020

SELL
$82.14 - $91.0 $18,152 - $20,111
-221 Reduced 4.12%
5,138 $447,000
Q2 2020

Aug 12, 2020

BUY
$80.93 - $91.1 $207,585 - $233,671
2,565 Added 91.8%
5,359 $468,000
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $197,451 - $276,633
2,794 New
2,794 $230,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.